Intraperitoneal Chemotherapy Alone or in Combination With Bevacizumab for Ovarian Cancer With Peritoneal Adhesion
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Pulsed Low Dose Rate Radiation With Concurrent Chemotherapy for Non-Small Cell Lung Cancer and Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
PDL-1 Targeting in Resectable Oesophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE3
Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)
- Status
- COMPLETED
- Phase
- PHASE3
Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients
- Status
- TERMINATED
- Phase
- PHASE1
Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003)
- Status
- UNKNOWN
- Phase
- PHASE2
Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
Immunotherapy as Second-line in Patient With Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of [14 C]-Pevonedistat in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3